BUCHANAN INGERSOLL & ROONEY PC for FERA PHARMACEUTICALS, LLC
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Strategy development and implementation of federal government relations initiatives relating to phospholine iodide issues with the Food and Drug Administration and Centers for Medicare and Medicaid Services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL P STRAZZELLA | — |
Medical/Disease Research/Clinical Labs MED
Strategy development and implementation of federal government relations initiatives relating to phospholine iodide issues with the Food and Drug Administration and Centers for Medicare and Medicaid Services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL P STRAZZELLA | — |
Medicare/Medicaid MMM
Strategy development and implementation of federal government relations initiatives relating to phospholine iodide issues with the Food and Drug Administration and Centers for Medicare and Medicaid Services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL P STRAZZELLA | — |
Pharmacy PHA
Strategy development and implementation of federal government relations initiatives relating to phospholine iodide issues with the Food and Drug Administration and Centers for Medicare and Medicaid Services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL P STRAZZELLA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.